Technology

BioCardia

$3.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-1.22%) Today
-$0.24 (-5.94%) As of 1:04 PM UTC after-hours

Why Robinhood?

You can buy or sell BioCardia and other stocks, options, and ETFs commission-free!

About BCDA

BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brand. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in San Carlos, CA. The listed name for BCDA is BioCardia, Inc. Common Stock.

CEO
Peter Alan Altman
Employees
24
Headquarters
San Carlos, California
Founded
1994
Market Cap
68.41M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
509.70K
High Today
$4.09
Low Today
$3.75
Open Price
$3.82
Volume
390.04K
52 Week High
$8.60
52 Week Low
$1.91

Collections

BCDA Earnings

-$0.46
-$0.31
-$0.15
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 9, Pre-Market

You May Also Like

IO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure